Related references
Note: Only part of the references are listed.The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure
Sophine B. Krintel et al.
RHEUMATOLOGY (2013)
Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis
Prapaporn Pisitkun et al.
IMMUNITY (2012)
Calcium Signaling in Systemic Lupus Erythematosus T Cells A Treatment Target
Vasileios C. Kyttaris et al.
ARTHRITIS AND RHEUMATISM (2011)
The many faces of Th17 cells
Anneli Peters et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6-lpr/lpr Mice
Vasileios C. Kyttaris et al.
JOURNAL OF IMMUNOLOGY (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Role of IL-23/IL-17 Axis in Lupus Nephritis
Zheng Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
Amit Awasthi et al.
JOURNAL OF IMMUNOLOGY (2009)
Share Paper
